TP53 and acute promyelocytic leukemia: The highest APL detection rates were observed in panels including mSDC2 with mSFRP1/2 or mTFPI2, as well as a five-biomarker mutational panel targeting APC, Bat-26, KRAS, L-DNA, and p53.